{"id":"taro-elixir","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108987","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Due to lack of information, a detailed explanation of the mechanism cannot be provided.","oneSentence":"Taro Elixir's mechanism of action is not publicly available.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:37:28.545Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01032499","phase":"PHASE3","title":"Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir","status":"UNKNOWN","sponsor":"Laboratorios Goulart S.A.","startDate":"2010-05","conditions":"Acne Vulgaris II or III Degree, Boils","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Taro Elixir","genericName":"Taro Elixir","companyName":"Laboratorios Goulart S.A.","companyId":"laboratorios-goulart-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}